AbbVie Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by AbbVie Inc. on September 29, 2015, reporting events that occurred on September 25, 2015. The filing details the entry into two new material definitive credit agreements to manage upcoming debt maturities.
Key Financial Metrics and Debt Structure
The filing does not provide revenue, profit, cash flow, or margin data. It focuses exclusively on new debt obligations:
- Three-Year Credit Agreement: A $2 billion term loan facility maturing three years after the closing date.
- 364-Day Credit Agreement: A $2 billion term loan facility maturing 364 calendar days after the closing date.
- Total New Facility Size: $4 billion in combined term loan commitments.
- Interest Rates: Variable rates based on Base Rate or Eurocurrency Rate plus an applicable margin. Margins for the 3-year loan range from 0.0% to 0.50% (Base) and 0.625% to 1.50% (Eurocurrency). Margins for the 364-day loan range from 0.0% to 0.25% (Base) and 0.5% to 1.25% (Eurocurrency).
- Administrative Agent: Bank of America, N.A.
Material Changes and Purpose
AbbVie entered into these agreements to address upcoming debt maturities. The filing represents a material change in the company's capital structure by creating new direct financial obligations totaling $4 billion. No prior period financial comparisons are included in this specific filing.
Management Commentary, Risks, and Covenants
Management intends to apply the proceeds from these facilities to refinance or address maturing debt. Both agreements contain customary affirmative and negative covenants, including a financial covenant, and standard events of default. The interest margins are tied to AbbVie's public debt rating at the time of borrowing.
Key Facts for Investor Verification
- Verify the specific "Closing Date" for both facilities, as advances are available only after this date subject to conditions.
- Confirm the current public debt rating of AbbVie to determine the exact applicable interest margin.
- Review the full text of the credit agreements (Exhibits 10.1 and 10.2) for specific financial covenant thresholds and negative covenants.
- Identify the specific upcoming maturities that these $4 billion in facilities are intended to replace.